Search Results - "Taber, Erin"
-
1
The Effect of Onset Age of Visual Deprivation on Visual Cortex Surface Area Across-Species
Published in Cerebral cortex (New York, N.Y. 1991) (13-09-2019)“…Blindness early in life induces permanent alterations in brain anatomy, including reduced surface area of primary visual cortex (V1). Bilateral enucleation…”
Get full text
Journal Article -
2
White matter lesions defined by diffusion tensor imaging in older adults
Published in Annals of neurology (01-09-2011)“…Objective: The cellular and molecular mechanisms underlying magnetic resonance imaging‐defined white matter (WM) changes associated with age‐related cognitive…”
Get full text
Journal Article -
3
Regional Patterns of Cerebral Cortical Differentiation Determined by Diffusion Tensor MRI
Published in Cerebral cortex (New York, N.Y. 1991) (01-12-2009)“…The morphology of axonal and dendritic arbors in the immature cerebral cortex influences the degree of anisotropy in water diffusion. This enables cortical…”
Get full text
Journal Article -
4
Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network
Published in Journal of medical imaging (Bellingham, Wash.) (01-01-2018)“…Diffusion weighted MRI has become ubiquitous in many areas of medicine, including cancer diagnosis and treatment response monitoring. Reproducibility of…”
Get full text
Journal Article -
5
Diffusion tensor imaging detects early cerebral cortex abnormalities in neuronal architecture induced by bilateral neonatal enucleation: an experimental model in the ferret
Published in Frontiers in systems neuroscience (01-01-2010)“…Diffusion tensor imaging (DTI) is a technique that non-invasively provides quantitative measures of water translational diffusion, including fractional…”
Get full text
Journal Article -
6
Phase 1b study to assess the safety of neoadjuvant trifluridine/tipiracil with concurrent radiation in resectable stage II/III rectal cancer
Published in Journal of clinical oncology (01-02-2023)“…TPS274 Background: Treatment of locally advanced rectal cancer currently involves tri-modal therapy with pre-operative chemo-radiation (CRT), surgery, and…”
Get full text
Journal Article -
7
Casper: A phase I, open-label, dose finding study of calaspargase pegol-mnkl (cala) in combination with cobimetinib (cobi) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC)
Published in Journal of clinical oncology (01-02-2023)“…TPS772 Background: Metabolic adaptation provides rapidly dividing cancer cells the flexibility to maintain homeostasis as nutrient supplies are continuously…”
Get full text
Journal Article -
8
A window of opportunity trial for metastatic (WOO-M) pancreatic ductal adenocarcinoma (PDAC): A biomarker discovery platform
Published in Journal of clinical oncology (01-02-2023)“…TPS781 Background: Even as the number of targeted agents increases, therapeutic options for PDAC patients remain limited by a lack of biomarkers that can…”
Get full text
Journal Article -
9
NeoOPTIMIZE: An open-label, phase II trial and biomarker discovery platform to assess the efficacy of adaptive switching of modified FOLFIRINOX (mFFX) or gemcitabine/nab-paclitaxel (GA) as a neoadjuvant strategy for patients with resectable/borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinoma (PDAC)
Published in Journal of clinical oncology (01-02-2022)“…Abstract only TPS630 Background: Neoadjuvant chemotherapy (NAC) and/or chemo-RT may confer benefit to patients with localized PDAC, by better tolerability,…”
Get full text
Journal Article -
10
Abstract B003: Advancing biomarker discovery using a novel window of opportunity (WOO) trial for pancreatic ductal adenocarcinoma: Trial updates
Published in Cancer research (Chicago, Ill.) (16-01-2024)“…Abstract Background: There are a growing number of targeted agents that have the potential to greatly improve the clinical outcomes of patients with PDAC…”
Get full text
Journal Article -
11
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
Published in Journal for immunotherapy of cancer (01-01-2023)“…In preclinical studies of pancreatic ductal adenocarcinoma (PDAC), ibrutinib improved the antitumor efficacy of the standard of care chemotherapy. This led to…”
Get full text
Journal Article